151 related articles for article (PubMed ID: 16750021)
1. [Exploration of prognostic factors in extranodal nasal-type NK/T cell lymphoma].
Han DM; Chen XQ; Bai QX
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):137. PubMed ID: 16750021
[No Abstract] [Full Text] [Related]
2. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.
Lee J; Park YH; Kim WS; Lee SS; Ryoo BY; Yang SH; Park KW; Kang JH; Park JO; Lee SH; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Ko YH; Ahn YC; Park K
Eur J Cancer; 2005 Jul; 41(10):1402-8. PubMed ID: 15963893
[TBL] [Abstract][Full Text] [Related]
3. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic analysis of 62 cases of nasal NK/T-cell lymphoma].
Xiao J; Wang SS; Huang Y; Chen LK; Guan ZZ; Huang HQ; Xia ZJ; Xu RH; Lin TY
Ai Zheng; 2006 Sep; 25(9):1173-7. PubMed ID: 16965665
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of concurrent chemoradiotherapy for stage I nasal NK/T cell lymphoma: a report of two cases.
Niibe Y; Hayakawa K; Kitano M; Ishiyama H; Nakayama M; Yao K; Okamoto M
Anticancer Res; 2005; 25(6C):4403-6. PubMed ID: 16334116
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type.
Wang B; Li XQ; Ma X; Hong X; Lu H; Guo Y
Am J Hematol; 2008 Oct; 83(10):795-9. PubMed ID: 18756548
[TBL] [Abstract][Full Text] [Related]
7. Disseminated nasal-type natural killer/T-cell lymphoma in a child: a case report.
Pellier I; N'Golet L; Rachieru P; Rousselet MC; Geneviève F; Moles MP; Hermine O; Rialland X
J Pediatr Hematol Oncol; 2009 May; 31(5):362-6. PubMed ID: 19415021
[TBL] [Abstract][Full Text] [Related]
8. Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study.
Lee J; Suh C; Park YH; Ko YH; Bang SM; Lee JH; Lee DH; Huh J; Oh SY; Kwon HC; Kim HJ; Lee SI; Kim JH; Park J; Oh SJ; Kim K; Jung C; Park K; Kim WS
J Clin Oncol; 2006 Feb; 24(4):612-8. PubMed ID: 16380410
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy.
Kim K; Chie EK; Kim CW; Kim IH; Park CI
Jpn J Clin Oncol; 2005 Jan; 35(1):1-5. PubMed ID: 15681596
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.
Liu X; Wang B; Ma X; Guo Y
Jpn J Clin Oncol; 2009 Jul; 39(7):418-24. PubMed ID: 19395464
[TBL] [Abstract][Full Text] [Related]
11. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
12. Three cases of extranodal NK/T-cell lymphoma of the nasal type diagnosed by nasal brush cytology.
Kishimoto K; Kitamura T; Hirayama Y; Tate G; Mitsuya T
Diagn Cytopathol; 2007 Feb; 35(2):125-9. PubMed ID: 17230578
[TBL] [Abstract][Full Text] [Related]
13. Extranodal NK/T-cell lymphoma with cutaneous involvement: 'nasal' vs. 'nasal-type' subgroups--a retrospective study of 18 patients.
Choi YL; Park JH; Namkung JH; Lee JH; Yang JM; Lee ES; Lee DY; Jang KT; Ko YH
Br J Dermatol; 2009 Feb; 160(2):333-7. PubMed ID: 19014396
[TBL] [Abstract][Full Text] [Related]
14. Extranodal NK/T-cell lymphoma, nasal type presenting as a pyogenic granuloma-like on a fingertip.
Fernández-Torres R; Del Pozo J; Alvarez A; Mazaira M; Varela C; Almagro M; Fonseca E
Eur J Dermatol; 2009; 19(1):79-80. PubMed ID: 19171539
[No Abstract] [Full Text] [Related]
15. Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type.
Shim SJ; Yang WI; Shin E; Koom WS; Kim YB; Cho JH; Suh CO; Kim JH; Kim GE
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):31-8. PubMed ID: 17049184
[TBL] [Abstract][Full Text] [Related]
16. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type.
Wu X; Li P; Zhao J; Yang X; Wang F; Yang YQ; Fang F; Xu Y; Zhang H; Wang WY; Yi C
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):619-25. PubMed ID: 18790372
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for classifying extranodal NK/T cell lymphoma, nasal type, as lymphoid neoplasia.
Na II; Kang HJ; Park YH; Lee SS; Yoo HJ; Choe DH; Ryoo BY; Yang SH
Eur J Haematol; 2007 Jul; 79(1):1-7. PubMed ID: 17598834
[TBL] [Abstract][Full Text] [Related]
18. [Nasal NK cell lymphoma with hemophagocytic syndrome developed tumor lysis syndrome after CHOP therapy].
Sawada M; Yamada T; Tsurumi H; Moriwaki H
Rinsho Ketsueki; 2002 Nov; 43(11):988-92. PubMed ID: 12508484
[TBL] [Abstract][Full Text] [Related]
19. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic predictors of nasal NK/T cell lymphoma detected by immunohistochemical staining].
Wang BY; Hong XN; Yin JL; Lu HF; Li XQ; Ma XJ; Guo Y
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):523-5. PubMed ID: 17147118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
